Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan

NCT05025956 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Femoroacetabular Impingement

Interventions

DRUG: Fisetin
DRUG: Placebo

Sponsor

Steadman Philippon Research Institute

Collaborators

[object Object]